Brief: Prostatype Genomics Q1 EBITDA Loss SEK 3.4 Mln
27/05/2021 07:39
May 27 (Reuters) - Prostatype Genomics AB PROGEN.ST :
* Q1 EBITDA (EARNINGS BEFORE INTEREST, TAXES, DEPRECIATION,
AND
AMORTIZATION) AMOUNTED TO -3 417 TSEK.
Source text for Eikon: ID:nWkr4mdh4G
Further company coverage: PROGEN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587696600;))
Recent news on Prostatype Genomics AB
See all newsBrief: Prostatype Genomics Resolves On Rights Issue To Raise About SEK 47.4 Mln
Brief: Prostatype Genomics Intends To Resolve On Rights Issue
Brief: Prostatype Genomics Reports H2 EBITDA Of SEK -17.8 Mln
Brief: Prostatype Genomics Signs Loan Financing Of SEK 10 Million
Brief: Prostatype Genomics Gets SEK 11.5 Mln Through Exercise Of Warrants